as a medium for the diffusion of knowledge on various aspects of diabetes within a worldwide scientific community. The early history of the journal was written 5 years ago in conjunction with the 20th anniversary [1] when a Jubilee Issue was published. The present editorial will neither repeat what was said in such a brilliant way nor give way to various thoughts of self-praise or self-criticism which may come into the mind of an editor on an occasion such as this.
In a previous editorial [2] I pointed out that a scientific journal is a quadruped with legs comprised of the authors, the referees, the readership and the publisher. The leading role of the authors in defining the quality of a scientific journal is indisputable, and after 25 years we owe a great deal of gratitude to all those clinical and basic scientists who have submitted their manuscripts to Diabetologia.
As a token of appreciation we have now taken the liberty of looking into the rear-view mirror to find out which of the authors have made the most-cited contributions to our journal over these years and which kinds of articles have been the most read and cited. With the aid of the Institute for Scientific Information in Philadelphia the 25 mostcited articles have been identified and the total number of citations calculated for each one.
The most-cited articles are listed in Table 1 . We have included only the first author's name in the Table and refer the interested reader to the Reference list for full information on each article. It is remarkable that the same author is the first and only name on the three top papers on the list. Lise Heding, working at the Novo Research Institute in Copenhagen, published, within 5 years, three papers related to the determination of islet-derived peptides in blood namely C-peptide, total serum insulin and pancreatic and gut glucagon. Each of these has been cited more than 400 times and the two foremost received their most frequent citations more than 12 years after publication. This is a most exceptional contribution and we are pleased to pay a tribute of gratitude to Dr. Heding.
A look at the geographic origin of the most cited articles shows Denmark in a leading position followed by USA, France and United Kingdom. Not surprisingly, authors from these countries are among those who, over the years, have submitted most manuscripts to the journal. A crude subdivision of all the papers in Table 1 Freychet, each appearing twice on the list. Finally, the time it takes for an article to reach its peak citation rate varies a great deal, although the shortest average time, about 3 years, is to be found among the review papers. It is also of some interest (and of considerable worry to the editor) that the most recent article on the list was published in 1980. I leave the interpretation of this observation to the readers.
What is listed in Table 1 is only the very tip of an iceberg of manuscripts which have been submitted during the last 25 years. Since 1965 over 6400 manuscripts have been scrutinized by the referees and the editors and have generated an endless flow of correspondence. Most probably these activities have also generated endless feelings of disappointment and frustration among those innumerable authors whose manuscripts were not accepted, and feelings of satisfaction among those select few whose product passed through the eye of the needle. Without this multitude of manuscripts our journal would not be what it is today and I express a sincere gratitude to all authors for their efforts and contributions.
This commemorative editorial should not end without an attempt to look into the crystal ball of the future. Glasnost and perestroikain the eastern parts of Europe with the opening of the borders for a free flow of individuals and ideas will probably boost the scientific activities including diabetology in this region. We invite our eastern colleagues to submit their manuscripts to Diabetologia and we hope they will subscribe to our journal. In the western part of Europe the development of the European Community should be a further incitement to medical research, and a growing interest in diabetes, one of the most common and devastating diseases of the area, can be anticipated: this, hopefully, will lead to increased circulation of our journal not only throughout Europe but worldwide. If, and when, these changes will lead to progress in diabetes research in terms of more efficient treatment and of cure and prevention of the disease is more difficult to assess. Looking back over the almost 70 years which have elapsed since the discovery of insulin it must be admitted that the progress in these regards has been limited. Manyblack boxes remain to be opened in our field of research and each is a challenge to our intellect and creativity. Meanwhile Diabetologia is proud to continue its role as an intermediary between those who expand the knowledge about diabetes and those who apply it to the care of their patients.
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